Acute basophilic leukemia lacking basophil-specific antigens: The importance of cytokine receptor expression in differential diagnosis

International Journal of Hematology

Volumn 75, Issue 3, 2002, Pages 309-313

  Yokohama, Akihiko ^a,d   Tsukamoto, Norifumi ^a   Hatsumi, Nahoko ^a   Suto, Miwa ^a   Akiba, Tohru ^a   Uchiumi, Hideki ^a   Maehara, Tadashi ^a   Matsushima, Takafumi ^a   Karasawa, Masamitsu ^a   Murakami, Hirokazu ^a   Shinonome, Shougo ^b   Saito, Hirohisa ^c   Nojima, Yoshihisa ^a  

^a GUNMA UNIVERSITY   (Japan)

^b Fujioka General Hospital   (Japan)

^c NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

Acute basophilic leukemia; CD116; CD117; CD123; Chemotherapy

Indexed keywords

CD123 ANTIGEN; COMPLEMENT COMPONENT C5A RECEPTOR; CYTARABINE; CYTOKINE; CYTOKINE RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; IDARUBICIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; STEM CELL FACTOR RECEPTOR; TOLONIUM CHLORIDE; ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN E RECEPTOR; LEUKOCYTE ANTIGEN;

ACUTE DISEASE; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLAST CELL; CANCER REGRESSION; CASE REPORT; CHEMOTHERAPY; DIFFERENTIAL DIAGNOSIS; ELECTRON MICROSCOPY; HUMAN; IMMUNOPHENOTYPING; MALE; MAST CELL LEUKEMIA; BLOOD; BONE MARROW; GENETICS; IMMUNOLOGY; MAST CELL; MIDDLE AGED; PATHOLOGY;

ANTIGENS, CD; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CYTARABINE; DIAGNOSIS, DIFFERENTIAL; HUMANS; IDARUBICIN; LEUKEMIA, BASOPHILIC, ACUTE; MALE; MAST CELLS; MIDDLE AGED; RECEPTORS, CYTOKINE; RECEPTORS, IGE;

EID: 0036551091     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02982048     Document Type: Article

References (33)

1. Ishii N, Murakami H, Matsushima T, et al. Histamine excess symptoms in basophilic crisis of chronic myelogenous leukemia. J Med. 1995;26:235-240.
2. Shimizu N, Kita K, Masuya M, et al. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines. Exp Hemtol. 1993;21:119-125.
3. Shekhter-Levin S, Penchansky L, Wollman M, Sherer M, Wald N, Gollin S. An abnormal clone with monosomy 7 and trisomy 21 in the bone marrow of a child with congenital agranulocytosis (Kostmann disease) treated with granulocyte colony-stimulating factor. Evolution towards myelodysplastic syndrome and basophilic leukemia. Cancer Genet Cytogenet. 1995;84:99-104.
4. Yamagata T, Miwa A, Eguchi M, et al. Transformation into acute basophilic leukemia in a patient with myelodysplastic syndrome. Br J Haematol. 1995;89:650-652.
5. Wick M, Li C-Y, Pierre R. Acute nonlymphocytic leukemia with basophilic differentiation. Blood. 1982;60:38-45.
6. Harris N, Jaffe E, Diebold J, et al. World health organization classification of neoplastic diseases of the hematopoietic and lymphoid tissue: report of the clinical advisory committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835-3849.
7. Bernini J, Timmons C, Sandler E. Acute basophilic leukemia in a child. Cancer. 1995;75:110-114.
8. Dastugue N, Duchayne E, Kuhlein E, et al. Acute basophilic leukaemia and translocation t(X;6)(p11;q23). Br J Haematol. 1997;98:170-176.
9. Peterson L, Parkin J, Arthur D, Brunning R. Acute basophilic leukemia. A clinical, morphologic, and cytogenetic study of eight cases. Am J Clin Pathol. 1991;96:160-170.
10. Scolyer R, Brun M, D'Rozario J, Webb M. Acute basophilic leukemia presenting with abnormal liver function tests and the absence of blast cells in the peripheral blood. Pathology. 2000;32:52-55.
11. Kempuraj D, Saito H, Kaneko A, et al. Characterization of mast cell-committed progenitors present in human umbilical cord blood. Blood. 1999;93:3338-3346.
12. Ahn K, Takai S, Pawankar R, et al. Regulation of chymase production in human mast cell progenitors. J Allergy Clin Immunol. 2000;106:321-328.
13. +, and expresses aminopeptidase N (CD13). Blood. 1999;94:2333-2342.
14. Vecchio L, Schiavone M, Ferara F, et al. Immunodiagnosis of acute leukemia displaying ectopic antigens: proposal for a classification of promiscuous phenotypes. Am J Hematol. 1989;31:173-180.
15. Duchayne E, Demur C, Rubie H, Robert A, Dastugue N. Diagnosis of acute basophilic leukemia. Leuk Lymph. 1999;32:269-278.
16. Invernizzi R, Iannone A, Bernuzzi S, et al. Acute promyelocytic leukemia toluidine blue subtype. Leuk Lymphoma. 1995;18:57-60.
17. Valent P. The phenotype of human eosinophils, basophils, and mast cells. J Allergy Clin Immunol. 1994;94:1177-1183.
18. Irani A, Nilsson G, Miettinen U, et al. Recombinant human stem cell factor stimulates differentiation of mast cells from dispersed human fetal liver cells. Blood. 1992;80:3009-3021.
19. Mitsui H, Furitsu T, Dvorak A, et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci U S A. 1993;90:735-739.
20. Valent P, Bettelheim P. Cell surface structures on human basophils and mast cells: biochemical and functional characterization. Adv Immunol. 1992;52:333-423.
21. Valent P, Spanblochl E, Sperr W, et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant stem cell factor/kit-ligand in long term culture. Blood. 1992;80:2237-2245.
22. Agis H, Füreder W, Bankl HC, et al. Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes. Immunology. 1996;87:535-543.
23. Valent P. Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes. Eur J Clin Invest. 1995;25:715-720.
24. Mayer P, Valent P, Schmidt G, Liehl E, Bettelheim P. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in non-human primates. Blood. 1989;74:613-621.
25. Saito H, Hatake K, Dvorak A, et al. Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. Proc Natl Acad Sci U S A. 1988;85:2288-2292.
26. Clutterbuck E, Hirst E, Sanderson C. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6, and GM-CSF. Blood. 1989;73:1504-1512.
27. Ema H, Suda T, Nagayoshi K, Miura Y, Civin C, Nakauchi H. Target cells for granulocyte colony-stimulating factor, Interleukin-3, and Interleukin-5 in differentiation pathways of neutrophils and eosinophils. Blood. 1990;76:1956-1961.
28. Budel L, Touw I, Delwel R, Clark S, Löwenberg B. Interleukin-3 and granulocyte-monocyte colony-stimulating factor receptors on human acute myelocytic leukemia cells and relationship to the proliferative response. Blood. 1989;74:565-571.
29. Toba K, Koike T, Shibata A, et al. Novel technique for the direct flow cytofluorometric analysis of human basophils in unseparated blood and bone marrow, and the characterization of phenotype and peroxidase of human basophil. Cytometry. 1999;35:249-259.
30. Kurosawa H, Eguchi M, Sakakibara H, Takahashi H, Furukawa T. Ultrastructural cytochemistry of congenital basophilic leukemia. Am J Pediatr Hematol Oncol. 1987;9:27-32.
31. Sigmund R, Vogelsang H, Machnik A, Herrmann D. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy. J Allergy Clin Immunol. 2000;106:1190-1195.
32. Bühring H-J, Simmons P, Pudney M. et al. The monoclonal antibody 97A6 a novel surface antigen expressed on human basophils and their multipotent and unipotent progenitors. Blood. 1999;94:2343-2356.
33. Koubek K, Kumberova A, Stary J, et al. Expression of cytokine receptors on different myeloid leukemic cells. Neoplasma. 1998;45:198-203.